Skip to main content
Fig. 1 | Journal of Pharmaceutical Health Care and Sciences

Fig. 1

From: Investigation of tolerability and quality of life for carboplatin-based chemotherapy in an elderly urothelial carcinoma patient undergoing hemodialysis: a case report

Fig. 1

Plasma concentration–time curves of carboplatin during the (a) first and (b) second chemotherapy cycle. The time intervals between the carboplatin infusion and the commencement of hemodialysis were 2 h in the first cycle and 1 h in the second cycle of gemcitabine plus carboplatin chemotherapy. Hemodialysis was performed for 3 h in each chemotherapy cycle. AUC: area under the concentration-time curve; HD, hemodialysis

Back to article page